--- title: Leveraging Adult Protective Service Interaction to Offer Evidence-Based Treatment for Depression in Elder Neglect/Self Neglect nct_id: NCT06910267 overall_status: NOT_YET_RECRUITING phase: NA sponsor: The University of Texas Health Science Center, Houston study_type: INTERVENTIONAL primary_condition: Depression in Old Age countries: United States canonical_url: "https://parkinsonspathways.com/agent/trials/NCT06910267.md" clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06910267" ct_last_update_post_date: 2025-07-02 last_seen_at: "2026-05-12T07:19:11.685Z" source: ClinicalTrials.gov (mirrored, no enrichment) --- # Leveraging Adult Protective Service Interaction to Offer Evidence-Based Treatment for Depression in Elder Neglect/Self Neglect **NCT ID:** [NCT06910267](https://clinicaltrials.gov/study/NCT06910267) ## Key Facts - **Status:** NOT_YET_RECRUITING - **Phase:** NA - **Study Type:** INTERVENTIONAL - **Target Enrollment:** 50 - **Lead Sponsor:** The University of Texas Health Science Center, Houston - **Collaborators:** National Institute on Aging (NIA) - **Conditions:** Depression in Old Age - **Start Date:** 2025-07-21 - **Completion Date:** 2026-03-31 - **CT.gov Last Update:** 2025-07-02 ## Brief Summary The purpose of this study is to test the feasibility and acceptability of an evidence-based treatment for depression delivered over an ipad, computer, or smartphone can help Adult Protective Services (APS) clients with their activities of daily living to evaluate whether reductions on measures of depression and apathy (a) mediate reduced Elder Neglect/Self Neglect (EN/SN) behaviors; and (b) whether secondary posited mediating mechanisms are also active in impacting depression and apathy ## Eligibility - **Minimum age:** 65 Years - **Sex:** ALL - **Healthy Volunteers:** No ``` Inclusion Criteria: * APS Case in APS Region VI- Must have open case * PHQ 9 score- Must have score of nine (9) or more Exclusion Criteria: * Previous mental health diagnosis of bipolar disorder, psychotic disorders, and moderate to severe dementia * Assessment of Consent Proxy- Those who need assessment of consent proxy * Suicidal Intent (as indexed by PhQ-9 question 9)- Those scoring 2 or 3 * Current Alcohol and Drug Dependency- As evidenced by Cut down, Annoyed, Guilty, and Eye-opener (CAGE) score of 3 or more ``` ## Arms - **APS Treatment as Usual** (ACTIVE_COMPARATOR) - **Intervention-Behavioral Activation (BA)** (EXPERIMENTAL) ## Interventions - **APS Treatment as Usual** (BEHAVIORAL) — APS agencies conduct in-home investigations of alleged abuse and neglect against disabled and older adults. Investigations result in short-term stop-gap measures, primarily brief case-management centering on referral linkage to community-based services and provision of resource allocation. No direct psychological services or treatments are provided by APS, however referral to other services is also standard. - **Intervention-Behavioral Activation (BA)** (BEHAVIORAL) — Participants will be will be guided through 8 one-hour sessions via home telehealth by the study community health worker. Each weekly \< 60 minute BA session will include modules focusing on 1) Psychoeducation for depression and techniques for self-management, including pharmacologic and psychosocial treatment options; 2) Introduction of BA and guided problem-solving techniques to enhance self efficacy for managing depression and other chronic illnesses; 3) BA and problem-solving techniques to support medication management and adherence strategies; 4) BA to develop strategies and techniques for communicating with health providers and/or support resources to foster positive mood and self management; and 5) Developing a relapse prevention plan, which includes identifying triggers for lower functioning, support resources, and practice of BA techniques. ## Primary Outcomes - **Change in depression as assessed by the Patient Depression Questionnaire (PHQ-9)** _(time frame: baseline, post-treatment ( 8 weeks after baseline), and 3 months)_ — This is 9 item questionnaire and each is scored from 0 (not at all) to 3 (nearly every day), for a maximum score of 27, higher score indicating more depression - **Change in apathy as assessed by the Apathy Motivations Index (AMI)** _(time frame: baseline, post-treatment ( 8 weeks after baseline), and 3 months)_ — This is an 18 item questionnaire and each item is scored on a scale from 0(completely true) to 4(completely untrue), for a maximum score of 72, with higher scores indicating greater apathy - **Change in Elder Neglect/Self Neglect (EN/SN) as evidenced by study developed goal attainment scale** _(time frame: baseline, post-treatment ( 8 weeks after baseline), and 3 months)_ — Participants will be given a list of 19 common daily activities and will be asked to pick one or more activities form the list that they would like to start doing or do more regularly each day or week.Each activity will be then scored based on the following scoring criteria, higher score indicating better outcome : (Much less than expected)-2 (Somewhat less than expected)-1 (Expected client outcome)0 (Somewhat better than expected)+1 (Much better than expected)+2 ## Secondary Outcomes - **Change in social connection as assessed by the Lubben Social Network Scale** _(time frame: baseline, post-treatment ( 8 weeks after baseline), and 3 months)_ - **Change in social isolation as assessed by Patient-Reported Outcomes Measurement Information System (PROMIS 8)** _(time frame: baseline, post-treatment ( 8 weeks after baseline), and 3 months)_ ## Locations (1) - The University of Texas Health Science Center at Houston, Houston, Texas, United States ## Recent Field Changes (last 30 days) - `status.overallStatus` — added _(2026-05-12)_ - `status.primaryCompletionDate` — added _(2026-05-12)_ - `status.completionDate` — added _(2026-05-12)_ - `status.lastUpdatePostDate` — added _(2026-05-12)_ - `design.phases` — added _(2026-05-12)_ - `design.enrollmentCount` — added _(2026-05-12)_ - `eligibility.criteria` — added _(2026-05-12)_ - `eligibility.minAge` — added _(2026-05-12)_ - `eligibility.sex` — added _(2026-05-12)_ - `outcomes.primary` — added _(2026-05-12)_ - `outcomes.secondary` — added _(2026-05-12)_ - `armsInterventions.arms` — added _(2026-05-12)_ - `armsInterventions.interventions` — added _(2026-05-12)_ - `sponsor.lead` — added _(2026-05-12)_ - `sponsor.collaborators` — added _(2026-05-12)_ - `results.hasResults` — added _(2026-05-12)_ - `locations.the university of texas health science center at houston|houston|texas|united states` — added _(2026-05-12)_ --- *Canonical: https://parkinsonspathways.com/agent/trials/NCT06910267.md* *Source data (authoritative): https://clinicaltrials.gov/study/NCT06910267* *This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*